Status:
UNKNOWN
Subclinical Diabetes Confirmed by 75gm-OGTT Influence on the Prognosis of Decompensated Cirrhosis
Lead Sponsor:
Yonsei University
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Brief Summary
Disorders of glucose metabolism, such as impaired glucose intolerance (IGT) and diabetes mellitus (DM), frequently occur in cirrhosis. However, it has been underestimated when fasting plasma glucose (...
Eligibility Criteria
Inclusion
- Liver cirrhosis
- Admitted to a hospital
Exclusion
- Previously confirmed DM
- Being treated for DM
- Standard risk factors of T2DM, such as high body mass index and family history of diabetes
- Symptoms of DM, such as increased thirst and the need to urinate
- Either hepatocellular carcinoma or other malignancy
- Hepatic failure or uncontrolled decompensation \[that is, refractory ascites or active variceal hemorrhage\]
- Significant illnesses such as sepsis that may have interfered with glucose metabolism
- Pancreatic dysfunction such as acute/chronic pancreatitis that may have affected glucose metabolism.
Key Trial Info
Start Date :
January 2 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2021
Estimated Enrollment :
1015 Patients enrolled
Trial Details
Trial ID
NCT04828512
Start Date
January 2 2007
End Date
December 30 2021
Last Update
April 2 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.